DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats ENA Respiratory has been awarded ...
Tag: Drug Development
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline
Organ-on-a-chip models allow researchers to conduct studies closer to real-life conditions Bringing a new drug to market costs billions of ...
Targeting Poxviruses with Messenger RNA Technology
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) working with industry partners are among the first ...
Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs
Internal Manufacturing Capabilities Expected to Support U.S. Pandemic Preparedness Tonix Pharmaceuticals will hold a ribbon-cutting ceremony at the company’s new ...
ATCC Announces Awards from DTRA Supporting Global Health and Biodefense
Novel work in small molecule antiviral therapies using artificial intelligence and machine learning for drug design and organoids for testing ...
Zika Virus Vaccine Shows Promising Results in Preclinical Studies
A Zika virus vaccine candidate is effective at preventing the Zika virus passing from mother to fetus in preclinical animal ...
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy
Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by ...
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule
Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with ...
Erica Ollmann Saphire Receives $2.6M Grant to Collaborate on Pan-Coronavirus Vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus ...
First-Ever Malaria Vaccine Has Roots in Army Medical Research
Following decades of research, the officials at the World Health Organization recently recommended the widespread use of the RTS,S/AS01 malaria ...
Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines
The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
Tonix Pharmaceuticals Opens Infectious Disease R&D Center in Maryland
A ribbon-cutting ceremony today at Tonix Pharmaceuticals marks the opening of a new 48,000 square foot Research and Development Center ...
VirusMED Atlas Centralizes Atomic Structures of Virus Strains
University of Virginia School of Medicine researchers, working with collaborators in China and Poland have developed an Internet information system, ...
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells
Scientists at Washington University School of Medicine in St. Louis are collaborating with the NIH researchers to test the MM3122 ...
Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development
Initiative funds research to explore how the microbiome affects severity of radiation injury and how the microbiome itself is impacted ...
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes
Named one of the top ten threats in 2019 by the World Health Organization, dengue is critically important to global health ...
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine
Dynavax Technologies Corporation and the U.S. Department of Defense (DOD) today announced an agreement for approximately $22 million over two and a half years to ...
Made-in-Melbourne mAbs Could Bolster Australia’s COVID Response
A COVID-19 treatment using monoclonal antibodies is one step closer thanks to the efforts of Australian researchers. Scientists found antibodies ...
Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates
Vaccination yields broad neutralizing antibody responses against original strain and Beta, Gamma and Delta variants CiVax™ is under development as ...
U.S. Invests $36.3M in Pan-Coronavirus Vaccine Development
The awards are intended to fuel vaccine research for a diverse family of coronaviruses, with a primary focus on potential ...
